Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1787.10
7.70 (0.43%) Sun Pharma Inds. - Quaterly Results
Date: 23-05-2026
The sales is pegged at Rs. 49238.80 millions for the March 2026 quarter. The mentioned figure indicates a decline of about -31.42% as against Rs. 71794.50 millions during the year-ago period.The Net Profit of the company slipped to Rs. 6087.00 millions from Rs. 20419.70 millions, a decline of -70.19% on QoQ basis.Operating Profit reported a sharp decline to 13919.00 millions from 31915.80 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 49238.80 | 71794.50 | -31.42 | 207546.40 | 229774.00 | -9.67 | 207546.40 | 229774.00 | -9.67 |
| Other Income | 629.30 | 1321.30 | -52.37 | 4193.30 | 3791.40 | 10.60 | 4193.30 | 3791.40 | 10.60 |
| PBIDT | 13919.00 | 31915.80 | -56.39 | 66000.20 | 72168.40 | -8.55 | 66000.20 | 72168.40 | -8.55 |
| Interest | 2169.20 | 2323.80 | -6.65 | 9478.40 | 9538.90 | -0.63 | 9478.40 | 9538.90 | -0.63 |
| PBDT | 11749.80 | 29592.00 | -60.29 | 51058.40 | 62629.50 | -18.48 | 51058.40 | 62629.50 | -18.48 |
| Depreciation | 3259.70 | 3054.40 | 6.72 | 13117.20 | 12867.40 | 1.94 | 13117.20 | 12867.40 | 1.94 |
| PBT | 8490.10 | 26537.60 | -68.01 | 37941.20 | 49762.10 | -23.75 | 37941.20 | 49762.10 | -23.75 |
| TAX | 2403.10 | 6117.90 | -60.72 | 11707.00 | 7481.30 | 56.48 | 11707.00 | 7481.30 | 56.48 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 6087.00 | 20419.70 | -70.19 | 26234.20 | 42280.80 | -37.95 | 26234.20 | 42280.80 | -37.95 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 28.27 | 44.45 | -36.41 | 31.80 | 31.41 | 1.25 | 31.80 | 31.41 | 1.25 |